Aimof this study was to assessment of 89 Sr therapy as pain treatment modality in the group of patients with multiple bone metastases.Material and methodsFrom January 2000 to October 2000 in our center were treated 41 patients; 17 – prostate cancer and 24 – breast cancer patients. All patients had applied only one dose of 150 MBq of 89 Sr. Before and follow-up each patient has been evaluated; performance status according to the Karnofsky Scale and paro intensity according the VAS scale. We did not observe any clinical important haematological side effects. The ionisation dosemetric monitoring of the sources and the radioactive refuse were recorded. The radioactive refuse was storage in special container when the activity decreased to the ba...
In this study we compared two methods of radiotherapy in patients with painful bone metastases: 20 G...
Bone seeking radiopharmaceuticals are indicated in cancer patients with multiple painful skeletal me...
Most patients with bony metastases experience painful symptoms. Strontium-89 isotope therapy is an a...
These retrospective study is aimed to evaluate the efficacy of therapy with Stronthium-chloride 89 (...
In patients with prostatic adenocarcinoma with bony metastasis, pain palliation is an important poin...
There are few options for treating painful bone metastasis in multiple sites. Hemibody irradiation, ...
Intractable bone pain secondary to bone metastasis from prostate or breast cancer, or other malignan...
Intractable bone pain secondary to bone metastasis from prostate or breast cancer, or other malignan...
Aim: The consecutive administration of two different bone seeking radio-pharmaceuticals such as 186R...
SummaryBackgroundApproximately 60–80% of metastatic prostate cancer patients suffer from pain caused...
A review was performed of all patients who received strontium-89 chloride or samarium-153 ethylenedi...
A multicentre observational study was conducted by the Italian Association of Nuclear Medicine betwe...
Hormone resistant phase of prostatic cancer develops after 16-24 months of hormone therapy of metast...
Aim —to evaluate the clinical efficiency of strontium-89 chloride in the treatment of pain syndrome ...
In this study we compared two methods of radiotherapy in patients with painful bone metastases: 20 G...
In this study we compared two methods of radiotherapy in patients with painful bone metastases: 20 G...
Bone seeking radiopharmaceuticals are indicated in cancer patients with multiple painful skeletal me...
Most patients with bony metastases experience painful symptoms. Strontium-89 isotope therapy is an a...
These retrospective study is aimed to evaluate the efficacy of therapy with Stronthium-chloride 89 (...
In patients with prostatic adenocarcinoma with bony metastasis, pain palliation is an important poin...
There are few options for treating painful bone metastasis in multiple sites. Hemibody irradiation, ...
Intractable bone pain secondary to bone metastasis from prostate or breast cancer, or other malignan...
Intractable bone pain secondary to bone metastasis from prostate or breast cancer, or other malignan...
Aim: The consecutive administration of two different bone seeking radio-pharmaceuticals such as 186R...
SummaryBackgroundApproximately 60–80% of metastatic prostate cancer patients suffer from pain caused...
A review was performed of all patients who received strontium-89 chloride or samarium-153 ethylenedi...
A multicentre observational study was conducted by the Italian Association of Nuclear Medicine betwe...
Hormone resistant phase of prostatic cancer develops after 16-24 months of hormone therapy of metast...
Aim —to evaluate the clinical efficiency of strontium-89 chloride in the treatment of pain syndrome ...
In this study we compared two methods of radiotherapy in patients with painful bone metastases: 20 G...
In this study we compared two methods of radiotherapy in patients with painful bone metastases: 20 G...
Bone seeking radiopharmaceuticals are indicated in cancer patients with multiple painful skeletal me...
Most patients with bony metastases experience painful symptoms. Strontium-89 isotope therapy is an a...